Keefe, Bruyette & Woods Forecasts Strong Price Appreciation for Ryan Specialty (NYSE:RYAN) Stock

Ryan Specialty (NYSE:RYAN – Get Free Report) had its price objective boosted by stock analysts at Keefe, Bruyette & Woods from $49.00 to $55.00 in a note issued to investors on Friday, MarketBeat reports. The brokerage presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods‘s price objective would suggest a potential upside of 16.85% from the stock’s previous close.

Several other equities analysts have also recently weighed in on RYAN. Barclays raised their price target on shares of Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. The Goldman Sachs Group increased their target price on shares of Ryan Specialty from $40.00 to $45.00 and gave the company a “neutral” rating in a report on Friday, July 31st. UBS Group dropped their price target on shares of Ryan Specialty from $55.00 to $52.00 and set a “buy” rating on the stock in a research report on Monday, November 2nd. Weiss Ratings upgraded shares of Ryan Specialty from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, September 18th. Finally, JPMorgan Chase & Co. boosted their target price on Ryan Specialty from $39.00 to $45.00 and gave the company an “underweight” rating in a research note on Monday, August 3rd. Eight investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $53.08.

Check Out Our Latest Research Report on Ryan Specialty

Ryan Specialty Stock Up 1.0%

Ryan Specialty stock opened at $47.07 on Friday. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty has a 52-week low of $29.28 and a 52-week high of $58.91. The firm has a 50 day moving average price of $41.93 and a two-hundred day moving average price of $39.00. The firm has a market cap of $11.84 billion, a price-to-earnings ratio of 58.11, a PEG ratio of 0.99 and a beta of 0.54.

Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, October 29th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.49 by $0.02. The company had revenue of $789.96 million during the quarter, compared to the consensus estimate of $792.99 million. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. During the same quarter last year, the firm posted $0.47 EPS. Equities analysts predict that Ryan Specialty will post 2.18 EPS for the current year.

Insider Buying and Selling

In related news, CEO Benjamin Wuller sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $47.31, for a total value of $2,365,500.00. Following the completion of the sale, the chief executive officer owned 94,095 shares in the company, valued at $4,451,634.45. The trade was a 34.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 52.03% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Ryan Specialty

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Allworth Financial LP lifted its holdings in Ryan Specialty by 70.0% in the 2nd quarter. Allworth Financial LP now owns 787 shares of the company’s stock worth $30,000 after buying an additional 324 shares during the period. Parallel Advisors LLC grew its position in shares of Ryan Specialty by 54.9% in the 1st quarter. Parallel Advisors LLC now owns 1,013 shares of the company’s stock worth $34,000 after buying an additional 359 shares during the last quarter. Fortitude Family Office LLC purchased a new position in shares of Ryan Specialty during the third quarter valued at approximately $34,000. Jacobi Capital Management LLC purchased a new position in shares of Ryan Specialty during the third quarter valued at approximately $42,000. Finally, Covestor Ltd increased its stake in shares of Ryan Specialty by 64.2% during the third quarter. Covestor Ltd now owns 1,956 shares of the company’s stock valued at $72,000 after buying an additional 765 shares during the period. 84.82% of the stock is currently owned by institutional investors.

About Ryan Specialty

(Get Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

Further Reading

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.